The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid addiction in the United States.
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback